(Circulation. 1997;95:766-770.)
© 1997 American Heart Association, Inc.
Articles |
Report of the National Heart, Lung, and Blood Institute Special Emphasis Panel on Heart Failure Research
the National Heart, Lung, and Blood Institute, Bethesda, Md (S.C.M., L.R.). See "Appendix" for a list of the members of the SEP on Heart Failure Research.
Correspondence to Leslie Reinlib, PhD, National Heart, Lung, and Blood Institute, Rockledge Center Two, 6701 Rockledge Dr, MSC 7940, Bethesda, MD 20892. E-mail LR25V@NIH.GOV.
Key Words: cardiovascular diseases • heart diseases • heart failure
 |
Introduction |
|---|
Heart failure is the final common pathway of most primary cardiovascular diseases, including coronary atherosclerosis, hypertension, cardiomyopathy, myocarditis, diabetes, and valvular and congenital heart malformations. Most treatments slow the course of these primary diseases but do not abolish them. As a result, an increasing proportion of the US population is living with heart disease and is at risk for heart failure. Approximately 400 000 new cases of heart failure occur annually, and recent estimates (1993) of its prevalence demonstrate the enormous burden exacted on the public: 4.7 million patients, with 1.5 million people younger than 65 years of age, and direct healthcare costs (drugs, nursing home care, professional services) totaling $17.8 billion each year. These numbers will likely increase as the US population ages.
In recognition of this national health problem, the National Heart, Lung, and Blood Institute (NHLBI) convened a Task Force on Research in Heart Failure and released the findings in 1994 to chart the course for future research. Given the explosion of new information and ideas, a Special Emphasis Panel (SEP) on Heart Failure Research was held on May 20, 1996, in Bethesda, Md, to follow up and focus the broad task force recommendations. The framework to conduct future research as recommended by these expert panels of extramural scientists is essential to promoting the needs of the biomedical community and properly committing the Institute's scarce resources.
The SEP members were experts representing a broad range of biomedical disciplines and were charged to consider an array of emerging
This article has been cited by other articles:
 |
|
 |
|
  D. Frenkel, A. S. Pachori, L. Zhang, A. Dembinsky-Vaknin, D. Farfara, S. Petrovic-Stojkovic, V. J. Dzau, and H. L. Weiner Nasal vaccination with troponin reduces troponin specific T-cell responses and improves heart function in myocardial ischemia-reperfusion injury Int. Immunol., July 1, 2009; 21(7): 817 - 829. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Klein and S. Danzi Thyroid Hormone Treatment to Mend a Broken Heart J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1172 - 1174. [Full Text] [PDF]
|
|
|
|
 |
|
 E. Castardeli, D. R. Duarte, M. F. Minicucci, P. S. Azevedo, B. B. Matsubara, L. S. Matsubara, A. O. Campana, S. A.R. Paiva, and L. A.M. Zornoff Tobacco smoke-induced left ventricular remodelling is not associated with metalloproteinase-2 or -9 activation Eur J Heart Fail, November 1, 2007; 9(11): 1081 - 1085. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. W. Rodenbaugh, W. Wang, J. Davis, T. Edwards, J. D. Potter, and J. M. Metzger Parvalbumin isoforms differentially accelerate cardiac myocyte relaxation kinetics in an animal model of diastolic dysfunction Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1705 - H1713. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Huber, I. Itzhaki, O. Caspi, G. Arbel, M. Tzukerman, A. Gepstein, M. Habib, L. Yankelson, I. Kehat, and L. Gepstein Identification and selection of cardiomyocytes during human embryonic stem cell differentiation FASEB J, August 1, 2007; 21(10): 2551 - 2563. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. T. Pleger, P. Most, and H. A. Katus S100 proteins: A missing piece in the puzzle of heart failure? Cardiovasc Res, July 1, 2007; 75(1): 1 - 2. [Full Text] [PDF]
|
|
|
|
 |
|
 S. T. Pleger, P. Most, M. Boucher, S. Soltys, J. K. Chuprun, W. Pleger, E. Gao, A. Dasgupta, G. Rengo, A. Remppis, et al. Stable Myocardial-Specific AAV6-S100A1 Gene Therapy Results in Chronic Functional Heart Failure Rescue Circulation, May 15, 2007; 115(19): 2506 - 2515. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Chen, W. Yong, S. Ren, W. Shen, Y. He, K. A. Cox, W. Zhu, W. Li, M. Soonpaa, R. M. Payne, et al. Overexpression of Bone Morphogenetic Protein 10 in Myocardium Disrupts Cardiac Postnatal Hypertrophic Growth J. Biol. Chem., September 15, 2006; 281(37): 27481 - 27491. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Yamada, Y. Ikeda, M. Yano, K. Yoshimura, S. Nishino, H. Aoyama, L. Wang, H. Aoki, and M. Matsuzaki Inhibition of protein phosphatase 1 by inhibitor-2 gene delivery ameliorates heart failure progression in genetic cardiomyopathy FASEB J, June 1, 2006; 20(8): 1197 - 1199. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. Pachori, L. G. Melo, L. Zhang, S. D. Solomon, and V. J. Dzau Chronic Recurrent Myocardial Ischemic Injury Is Significantly Attenuated by Pre-Emptive Adeno-Associated Virus Heme Oxygenase-1 Gene Delivery J. Am. Coll. Cardiol., February 7, 2006; 47(3): 635 - 643. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Thum, J. Bauersachs, P. A. Poole-Wilson, H.-D. Volk, and S. D. Anker The Dying Stem Cell Hypothesis: Immune Modulation as a Novel Mechanism for Progenitor Cell Therapy in Cardiac Muscle J. Am. Coll. Cardiol., November 15, 2005; 46(10): 1799 - 1802. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Iwasaki, K. Mukasa, M. Yoneda, S. Ito, Y. Yamada, Y. Mori, N. Fujisawa, T. Fujisawa, K. Wada, H. Sekihara, et al. Marked attenuation of production of collagen type I from cardiac fibroblasts by dehydroepiandrosterone Am J Physiol Endocrinol Metab, June 1, 2005; 288(6): E1222 - E1228. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Zhang Prenatal Hypoxia and Cardiac Programming Reproductive Sciences, January 1, 2005; 12(1): 2 - 13. [Abstract] [PDF]
|
|
|
|
 |
|
 A. S. Pachori, L. G. Melo, M. L. Hart, N. Noiseux, L. Zhang, F. Morello, S. D. Solomon, G. L. Stahl, R. E. Pratt, and V. J. Dzau Hypoxia-regulated therapeutic gene as a preemptive treatment strategy against ischemia/reperfusion tissue injury PNAS, August 17, 2004; 101(33): 12282 - 12287. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Thompson and J. R. Balser Perioperative cardiac arrhythmias Br. J. Anaesth., July 1, 2004; 93(1): 86 - 94. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Lee and R. R. Makkar Stem-Cell Transplantation in Myocardial Infarction: A Status Report Ann Intern Med, May 4, 2004; 140(9): 729 - 737. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. McMullen, T. Shioi, W.-Y. Huang, L. Zhang, O. Tarnavski, E. Bisping, M. Schinke, S. Kong, M. C. Sherwood, J. Brown, et al. The Insulin-like Growth Factor 1 Receptor Induces Physiological Heart Growth via the Phosphoinositide 3-Kinase(p110{alpha}) Pathway J. Biol. Chem., February 6, 2004; 279(6): 4782 - 4793. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Moorjani, P. Catarino, R. El-Sayed, S. Al-Ahmed, B. Meyer, F. Al-Mohanna, and S. Westaby A pressure overload model to track the molecular biology of heart failure Eur. J. Cardiothorac. Surg., December 1, 2003; 24(6): 920 - 925. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Venkatraman, K. Harada, A. V. Gomes, W. G. L. Kerrick, and J. D. Potter Different Functional Properties of Troponin T Mutants That Cause Dilated Cardiomyopathy J. Biol. Chem., October 24, 2003; 278(43): 41670 - 41676. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. McMullen, T. Shioi, L. Zhang, O. Tarnavski, M. C. Sherwood, P. M. Kang, and S. Izumo Phosphoinositide 3-kinase(p110{alpha}) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy PNAS, October 14, 2003; 100(21): 12355 - 12360. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Porter, M. C. Heidkamp, B. T. Scully, N. Patel, J. L. Martin, and A. M. Samarel Isoenzyme-selective regulation of SERCA2 gene expression by protein kinase C in neonatal rat ventricular myocytes Am J Physiol Cell Physiol, July 1, 2003; 285(1): C39 - C47. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Juhasz, Y. Zhu, R. Garg, S. V. Anisimov, and K. R. Boheler Analysis of altered genomic expression profiles in the senescent and diseased myocardium using cDNA microarrays Eur J Heart Fail, December 1, 2002; 4(6): 687 - 697. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Gepstein Derivation and Potential Applications of Human Embryonic Stem Cells Circ. Res., November 15, 2002; 91(10): 866 - 876. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. LaPointe, X.-P. Yang, O. A. Carretero, and Q. He Left ventricular targeting of reporter gene expression in vivo by human BNP promoter in an adenoviral vector Am J Physiol Heart Circ Physiol, October 1, 2002; 283(4): H1439 - H1445. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B.G. PETRICH, P. LIAO, and Y. WANG Using a Gene-switch Transgenic Approach to Dissect Distinct Roles of MAP Kinases in Heart Failure Cold Spring Harb Symp Quant Biol, January 1, 2002; 67(0): 429 - 438. [Abstract] [PDF]
|
|
|
|
 |
|
 R. VON HARSDORF Can cardiomyocytes divide? Heart, November 1, 2001; 86(5): 481 - 482. [Full Text] [PDF]
|
|
|
|
|
|
C. Iribarren, A. J. Karter, A. S. Go, A. Ferrara, J. Y. Liu, S. Sidney, and J. V. Selby Glycemic Control and Heart Failure Among Adult Patients With Diabetes Circulation, June 5, 2001; 103(22): 2668 - 2673. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Pouzet, J.-T. Vilquin, A. A. Hagege, M. Scorsin, E. Messas, M. Fiszman, K. Schwartz, and P. Menasche Factors affecting functional outcome after autologous skeletal myoblast transplantation Ann. Thorac. Surg., March 1, 2001; 71(3): 844 - 851. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. SUH, E. T. SHIGENO, J. D. MORROW, B. COX, A. E. ROCHA, B. FREI, and T. M. HAGEN Oxidative stress in the aging rat heart is reversed by dietary supplementation with (R)-{alpha}-lipoic acid FASEB J, March 1, 2001; 15(3): 700 - 706. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kamisago, S. D. Sharma, S. R. DePalma, S. Solomon, P. Sharma, B. McDonough, L. Smoot, M. P. Mullen, P. K. Woolf, E. D. Wigle, et al. Mutations in Sarcomere Protein Genes as a Cause of Dilated Cardiomyopathy N. Engl. J. Med., December 7, 2000; 343(23): 1688 - 1696. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Badorff, B. Fichtlscherer, R. E. Rhoads, A. M. Zeiher, A. Muelsch, S. Dimmeler, and K. U. Knowlton Nitric Oxide Inhibits Dystrophin Proteolysis by Coxsackieviral Protease 2A Through S-Nitrosylation : A Protective Mechanism Against Enteroviral Cardiomyopathy Circulation, October 31, 2000; 102(18): 2276 - 2281. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Moriyama, H. Yasue, M. Yoshimura, Y. Mizuno, K. Nishiyama, R. Tsunoda, H. Kawano, K. Kugiyama, H. Ogawa, Y. Saito, et al. The Plasma Levels of Dehydroepiandrosterone Sulfate Are Decreased in Patients with Chronic Heart Failure in Proportion to the Severity J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 1834 - 1840. [Abstract] [Full Text]
|
|
|
|
|
|
M. O. Boluyt and O. H.L. Bing Matrix gene expression and decompensated heart failure: The aged SHR model Cardiovasc Res, May 1, 2000; 46(2): 239 - 249. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. H. Redfern, M. Y. Degtyarev, A. T. Kwa, N. Salomonis, N. Cotte, T. Nanevicz, N. Fidelman, K. Desai, K. Vranizan, E. K. Lee, et al. Conditional expression of a Gi-coupled receptor causes ventricular conduction delay and a lethal cardiomyopathy PNAS, April 25, 2000; 97(9): 4826 - 4831. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Fatkin, C. MacRae, T. Sasaki, M. R. Wolff, M. Porcu, M. Frenneaux, J. Atherton, H. J. Vidaillet, S. Spudich, U. De Girolami, et al. Missense Mutations in the Rod Domain of the Lamin A/C Gene as Causes of Dilated Cardiomyopathy and Conduction-System Disease N. Engl. J. Med., December 2, 1999; 341(23): 1715 - 1724. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ide, H. Tsutsui, S. Kinugawa, H. Utsumi, D. Kang, N. Hattori, K. Uchida, K.-i. Arimura, K. Egashira, and A. Takeshita Mitochondrial Electron Transport Complex I Is a Potential Source of Oxygen Free Radicals in the Failing Myocardium Circ. Res., August 20, 1999; 85(4): 357 - 363. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Perez-Terzic, A. M. Gacy, R. Bortolon, P. P. Dzeja, M. Puceat, M. Jaconi, F. G. Prendergast, and A. Terzic Structural Plasticity of the Cardiac Nuclear Pore Complex in Response to Regulators of Nuclear Import Circ. Res., June 11, 1999; 84(11): 1292 - 1301. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Peterson, H. Ju, J. Hao, M. Panagia, D. C. Chapman, and I. M.C. Dixon Expression of Gi-2{alpha} and Gs{alpha} in myofibroblasts localized to the infarct scar in heart failure due to myocardial infarction Cardiovasc Res, March 1, 1999; 41(3): 575 - 585. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. F. Clemo, B. S. Stambler, and C. M. Baumgarten Persistent Activation of a Swelling-Activated Cation Current in Ventricular Myocytes From Dogs With Tachycardia-Induced Congestive Heart Failure Circ. Res., July 27, 1998; 83(2): 147 - 157. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Anversa and J. Kajstura Ventricular Myocytes Are Not Terminally Differentiated in the Adult Mammalian Heart Circ. Res., July 13, 1998; 83(1): 1 - 14. [Full Text] [PDF]
|
|
|
|
|
|
H. Ju, S. Zhao, P. S. Tappia, V. Panagia, and I. M. C. Dixon Expression of Gq{alpha} and PLC-ß in Scar and Border Tissue in Heart Failure Due to Myocardial Infarction Circulation, March 10, 1998; 97(9): 892 - 899. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. O'Rourke and L. Reinlib Priorities in Heart Failure Research • Response Circulation, January 27, 1998; 97(3): 296 - 296. [Full Text]
|
|
|
|
|
|
J. Leor, H. Prentice, V. Sartorelli, M. J Quinones, M. Patterson, L. K Kedes, and R. A Kloner Gene transfer and cell transplant: an experimental approach to repair a 'broken heart' Cardiovasc Res, September 1, 1997; 35(3): 431 - 441. [Full Text] [PDF]
|
|
|
|
|
|
P. Liao, D. Georgakopoulos, A. Kovacs, M. Zheng, D. Lerner, H. Pu, J. Saffitz, K. Chien, R.-P. Xiao, D. A. Kass, et al. The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy PNAS, October 9, 2001; 98(21): 12283 - 12288. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Moss, W. Zareba, W. J. Hall, H. Klein, D. J. Wilber, D. S. Cannom, J. P. Daubert, S. L. Higgins, M. W. Brown, M. L. Andrews, et al. Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction N. Engl. J. Med., March 21, 2002; 346(12): 877 - 883. [Abstract] [Full Text] [PDF]
|
|